EPO revokes key Moderna patent for mRNA vaccines
In September, the EPO Boards of Appeal revoked a key patent for mRNA vaccines, on the basis of which Moderna had brought legal action against BioNTech and Pfizer. During the two-day oral hearing, Board of Appeal 3.3.08 revoked EP 3 590 949, which had previously been upheld at first instance.